Acurx Pharmaceuticals, Inc.盘中异动临近午盘股价大涨5.20%

自选股智能写手08-15

北京时间2024年08月15日23时32分，Acurx Pharmaceuticals, Inc.（ACXP.us）股票出现异动，股价大幅拉升5.20%。截至发稿，该股报2.00美元/股，成交量2.6844万股，换手率0.17%，振幅4.73%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-4.12百万美元，每股收益-0.26美元，毛利0.00美元，市盈率-1.72倍。机构评级方面，在...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2459982474?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-15 23:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2459982474","market":"us","top_or_hot":-1,"title":"Acurx Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.20%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年08月15日23时32分，Acurx Pharmaceuticals, Inc.（ACXP.us）股票出现异动，股价大幅拉升5.20%。截至发稿，该股报2.00美元/股，成交量2.6844万股，换手率0.17%，振幅4.73%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-4.12百万美元，每股收益-0.26美元，毛利0.00美元，市盈率-1.72倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815233213a1d47518&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Acurx Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.20%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAcurx Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.20%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-15 23:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815233213a1d47518&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年08月15日23时32分，Acurx Pharmaceuticals, Inc.（ACXP.us）股票出现异动，股价大幅拉升5.20%。截至发稿，该股报2.00美元/股，成交量2.6844万股，换手率0.17%，振幅4.73%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-4.12百万美元，每股收益-0.26美元，毛利0.00美元，市盈率-1.72倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815233213a1d47518&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815233213a1d47518&s=b","article_id":"2459982474","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815233213a1d47518&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2459982474","pubTimestamp":1723735933,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年08月15日23时32分，Acurx Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.20%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.16%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","BK4563":"昨日强势股","BK4539":"次新股","ACXP":"Acurx Pharmaceuticals, LLC*"},"translate_title":"Acurx Pharmaceuticals, Inc. 's intraday movement surged 5.20% near midday","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACXP":0.9},"content_text":"北京时间2024年08月15日23时32分，Acurx Pharmaceuticals, Inc.（ACXP.us）股票出现异动，股价大幅拉升5.20%。截至发稿，该股报2.00美元/股，成交量2.6844万股，换手率0.17%，振幅4.73%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-4.12百万美元，每股收益-0.26美元，毛利0.00美元，市盈率-1.72倍。机构评级方面，在所有2家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.16%。其相关个股中，Cingulate Inc.、Tempest Therapeutics, Inc.、Geovax Labs Inc C/Wts 29/09/2025(To Pur Com)涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为6698.35%、2079.87%、579.46%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 (To Pur Com)、Tempest Therapeutics, Inc.、Cingulate Inc.，振幅分别为103.98%、79.83%、70.46%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2459982474"}

Acurx Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.20%

精彩评论

Acurx Pharmaceuticals, Inc.盘中异动临近午盘股价大涨5.20%